A clinical study of Cytomegalovirus vaccine
Latest Information Update: 15 Jul 2022
At a glance
- Drugs SPYVLP 102 (Primary)
- Indications Cytomegalovirus infections
- Focus Adverse reactions
- 12 Jul 2022 According to a SpyBiotech media release, this clinical study is planned in 2023.
- 11 Sep 2020 New trial record
- 08 Sep 2020 According to a SpyBiotech media release, the expect to initiate this study in 2021.